Company
Science
Products
Animals
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
CLOSE
R & D
Patients
Veterinarians
IR
Jobs
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
News
> IR > News
News
Events
Report
제목
대웅펫과 반려견 혁신신약 독점판권 계약
작성자
관리자
등록일
22-01-18
조회수
3,592
플럼라인생명과학은 지난 2022년 1월 14일 대웅펫과 노령견을 위한
PLS-D1000 반려견 DNA면역조절제 후보군의 국내 독점판매권리 계약을 체결했다.
https://news.mt.co.kr/mtview.php?no=2022011713425764228
목록
공지사항
이전글
반려견 DNA면역항암제'PLS-D5000' 3상 계획 승인
공지사항
다음글
내년 주요 제품 기술수출 확대될 것